GSK logo linking to the homepage Menu Our use of animals At GSK we believe we have a moral responsibility to ensure good welfare and treatment of the animals in our care. We follow scientific principles to ensure that we prevent or minimise pain and distress before, during, and after experimental procedures. We have a company-wide policy that covers the standards of care and the ethical treatment of animals in research. The policy defines and drives the standards for our animal work. All GSK research must comply with this policy. The core principles laid out in this policy require that, as a minimum, all animals in our care must have access to: food, water and housing appropriate to their species humane care and a programme of veterinary care This policy also outlines requirements for study design and approval, including that studies must: follow the principles of the 3Rs - replacement, reduction and refinement - in the design of animal studies be reviewed by an ethical review panel take measures to minimise any pain or distress to animals be performed by appropriately trained staff All of our staff involved in animal studies receive training in standards of care and ethics on the use of animals in research. All of our facilities and programmes comply with the national laws, guidelines and codes of conduct for that country. In situations where we have recently acquired a company, we will work closely with that group to ensure that our animal welfare standards align. Given the size and complexity of the task, this can take some time. Find out more The 3Rs in medicine research Find out more about the 3Rs when animals are used in medicine research Use of non-human primates Medicines and vaccines need to be studied in an animal where the physiology and disease process is similar to that in humans Frequently asked questions We provide answers to some of the most commonly asked questions about our research involving animals GSK Quick links Behind the science About us Products Careers Investors Media Research Responsibility Legal Terms of use Cookie policy Privacy Notice Modern Slavery Act statement 2017 PDF - 199.6KB Accessibility Sitemap Accessibility Contact us Contact us Partnerships Report a possible side effect Business to business Supplier website Business to business © 2001-2018 GlaxoSmithKline plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.